An MIT study on clinical trial success rates found that the overall probability of success for all drugs and vaccines is 13.8 percent. Two-thirds of trial failures occur due to inadequate efficiency,...
Researchers develop a new therapeutic approach against chronic obstructive pulmonary disease (COPD) by preventing lung epithelial cell death and encouraging lung epithelial cell regeneration. More...
Announced on 12 May 2020, Proteona and Professor Nikolai Petrovsky from Flinders University will be partnering to to characterize the clinical response to a new SARS-CoV-2 vaccine. Professor...
Funding round will support Emergex’s pipeline of set-point vaccines for infectious diseases. Based in the United Kingdom, Emergex is a biotechnology company that develops set-point vaccines to...
A new hospital in New Hongqiao International Medical centre has become a centre for trials of healthcare reform, which encourages doctors to work in different medical facilities and introduce new...
More effective seasonal flu vaccine to be tested in clinical trials. It was found that the current flu vaccine was 47 per cent effective before a flu bug emerged halfway through the season,...
Rising IND submissions are driving preclinical CRO market growth in Asia. Charlene Chen shares three criteria when selecting a CRO partner that can take you from preclinical through Phase II and...
Ross Rothmeier shares how AI is being applied in the recruitment process of clinical trials. by Ross Rothmeier The success of clinical trials will soon no longer be enshrined in two sacred numbers -...
Clinical trials are the make-or-break stage of a drug’s long journey from initial discovery to eventual commercialisation. What happens in clinical trials? Who are involved? Why is the failure rate...
SUNRISE, BATMAN and GEMSTONE, who comes up with these names? by Lim Guan Yu Clinical trials are research studies conducted to investigate potential treatments such as a new drug compound and its...
Elderly often under-represented in clinical trials. Two studies provide new insights on the efficacy and safety of immunotherapy in elderly patients with advanced non-small-cell lung cancer (NSCLC),...
